BlossomHill Therapeutics, Inc. BLSM
IPO
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 95.38M | 116.00M | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 2.59M | 3.72M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 3.00M | -- | -- | ||
| Total Current Assets | 100.97M | 119.72M | -- | ||
|
|
|||||
| Total Current Assets | 100.97M | 119.72M | -- | ||
| Net Property, Plant & Equipment | 20.69M | 21.21M | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 2.48M | 2.48M | -- | ||
| Total Assets | 124.13M | 143.41M | -- | ||
|
|
|||||
| Total Accounts Payable | 3.93M | 5.38M | -- | ||
| Total Accrued Expenses | 12.73M | 10.31M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 1.15M | 493.00K | -- | ||
| Total Finance Division Other Current Liabilities | 809.00K | -- | -- | ||
| Total Other Current Liabilities | 809.00K | -- | -- | ||
| Total Current Liabilities | 18.62M | 16.18M | -- | ||
|
|
|||||
| Total Current Liabilities | 18.62M | 16.18M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 22.22M | 22.53M | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 1.25M | -- | -- | ||
| Total Liabilities | 42.09M | 38.71M | -- | ||
|
|
|||||
| Common Stock & APIC | 5.02M | 3.92M | -- | ||
| Retained Earnings | -179.80M | -156.04M | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | -174.78M | -152.12M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | 256.82M | 256.82M | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | 256.82M | 256.82M | -- | ||
|
|
|||||
| Total Common Equity | -174.78M | -152.12M | -- | ||
| Total Preferred Equity | 256.82M | 256.82M | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 82.04M | 104.70M | -- | ||
|
|
|||||